PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Product: Irbesartan
Presentation Product Chemical substance Chapter Items dispensed
Irbesartan 300mg tablets
0205052I0AAACAC
Irbesartan Irbesartan Cardiovascular System 163,040
Irbesartan 150mg tablets
0205052I0AAABAB
Irbesartan Irbesartan Cardiovascular System 140,770
Irbesartan 75mg tablets
0205052I0AAAAAA
Irbesartan Irbesartan Cardiovascular System 87,188
Irbesartan 300mg/5ml oral suspension
0205052I0AAAGAG
Irbesartan Irbesartan Cardiovascular System 19
Irbesartan 150mg/5ml oral suspension
0205052I0AAAFAF
Irbesartan Irbesartan Cardiovascular System 12
Irbesartan 100mg/5ml oral suspension
0205052I0AAAMAM
Irbesartan Irbesartan Cardiovascular System No data available
Irbesartan 20mg oral powder sachets
0205052I0AAAJAJ
Irbesartan Irbesartan Cardiovascular System No data available
Irbesartan 300mg oral powder sachets
0205052I0AAAIAI
Irbesartan Irbesartan Cardiovascular System No data available
Irbesartan 30mg oral powder sachets
0205052I0AAAKAK
Irbesartan Irbesartan Cardiovascular System No data available
Irbesartan 37.5mg oral powder sachets
0205052I0AAALAL
Irbesartan Irbesartan Cardiovascular System No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.